Medicare Enrolled

Dr. Preeti Chopra, M.D.

Internal Medicine · Oxnard, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
451 W GONZALES RD, Oxnard, CA 93036
8056439986
In practice since 2008 (18 years)
NPI: 1699951202 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chopra from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chopra? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chopra

Dr. Preeti Chopra is an internal medicine specialist in Oxnard, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Chopra performed 866 Medicare services across 300 unique beneficiaries.

Between the years covered by Open Payments, Dr. Chopra received a total of $92,821 from 38 pharmaceutical and/or device companies across 886 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chopra is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 36% volume in CA $92,821 industry payments

Medicare Practice Summary

Medicare Utilization ↗
866
Medicare services
Top 36% in CA for internal medicine
300
Unique beneficiaries
$33
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~48 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Allergy injection therapy, multiple injections
A professional service involving the administration of multiple allergen injections.
242 $10 $40
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
185 $12 $69
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
164 $100 $145
Health risk assessment administration and interpretation
This procedure involves administering a health risk assessment to a patient and interpreting the results.
152 $2 $20
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
37 $60 $115
Nitric oxide gas level test
A test that measures the level of nitric oxide gas in the body.
25 $17 $30
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
22 $94 $200
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
20 $134 $250
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
19 $18 $35
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$92,821
Total received (2018-2024)
Avg $13,260/year across 7 years
Top 2% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
886
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$68,763 (74.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,153 (19.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,905 (6.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$19,337
2023
$42,234
2022
$6,274
2021
$3,913
2020
$3,468
2019
$12,958
2018
$4,637

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$16,466
GlaxoSmithKline, LLC.
$648
Amgen Inc.
$463
Regeneron Healthcare Solutions, Inc.
$270
Genentech USA, Inc.
$250
Blueprint Medicines Corporation
$249
GENZYME CORPORATION
$163
Novartis Pharmaceuticals Corporation
$160
PFIZER INC.
$132
Octapharma USA, Inc.
$81
SANOFI-AVENTIS U.S. LLC
$80
Takeda Pharmaceuticals U.S.A., Inc.
$72
Pharming Healthcare, Inc.
$71
Optinose US, Inc.
$47
CSL Behring
$44
Grifols USA, LLC
$41
Lilly USA, LLC
$31
BioCryst US Sales Co., LLC
$31
Hikma Pharmaceuticals USA
$21
ALK-Abello, Inc
$18
Top 3 companies account for 90.9% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$49,775
Shire North American Group Inc
$7,299
OptiNose US, Inc.
$5,640
GlaxoSmithKline, LLC.
$5,341
GENZYME CORPORATION
$3,728
Regeneron Healthcare Solutions, Inc.
$3,382
ALK-Abello, Inc
$3,019
Optinose US, Inc.
$2,514
Takeda Pharmaceuticals U.S.A., Inc.
$2,269
Blueprint Medicines Corporation
$1,925
Grifols USA, LLC
$1,648
Amgen Inc.
$1,195
Novartis Pharmaceuticals Corporation
$880
Bio Products Laboratory USA, Inc.
$536
PFIZER INC.
$523
Genentech USA, Inc.
$423
CSL Behring
$380
Octapharma USA, Inc.
$365
Boehringer Ingelheim Pharmaceuticals, Inc.
$296
BioCryst US Sales Co., LLC
$285
Horizon Therapeutics plc
$219
SANOFI-AVENTIS U.S. LLC
$175
kaleo, Inc.
$161
ABBVIE INC.
$118
Mylan Specialty L.P.
$106
Phadia US Inc.
$100
Pharming Healthcare, Inc.
$71
ADMA BioManufacturing LLC
$63
Incyte Corporation
$57
Kaleo, Inc.
$52
Circassia Pharmaceuticals Inc
$48
Teva Pharmaceuticals USA, Inc.
$47
Covis Pharma GmBH
$40
Hikma Pharmaceuticals USA
$36
Merck Sharp & Dohme LLC
$31
Lilly USA, LLC
$31
Aimmune Therapeutics, Inc.
$24
Merck Sharp & Dohme Corporation
$20
Top 3 companies account for 67.6% of all-time payments
Associated products mentioned in payments ›
ACTIMMUNE · AIRSUPRA · ALVESCO · ANORO · ANORO ELLIPTA · AUVI-Q · AYVAKIT · Auvi-Q · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · CINRYZE · CUTAQUIG · CUVITRU · DALIRESP · DUPIXENT · EBGLYSS · EUCRISA · FASENRA · Gammaplex · Grastek · HYQVIA · Haegarda · Hizentra · ImmunoCAP · NIOX VERO · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPZELURA · ORLADEYO · Odactra · Orladeyo · PALFORZIA · PANZYGA · ProAir Digihaler · RINVOQ · RUCONEST · Rituxan · Ryaltris · STANDARDIZED · STIOLTO RESPIMAT · SYMBICORT · TAKHZYRO · TEZSPIRE · TIMOTHY · TRELEGY ELLIPTA · XOLAIR · Xembify · Xhance · Xolair · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (74%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for internal medicine in CA.

Looking for an internal medicine specialist in Oxnard?
Compare internal medicine physicians in the Oxnard area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
305
Per 100K population
36.4
County median income
$107,327
Nearest hospital
ST JOHNS REGIONAL MEDICAL CENTER
3.2 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Chopra is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 2% of CA peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Chopra experienced with allergy injection therapy, multiple injections?
Based on Medicare claims data, Dr. Chopra performed 242 allergy injection therapy, multiple injections services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chopra receive payments from pharmaceutical companies?
Yes. Dr. Chopra received a total of $92,821 from 38 companies across 886 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chopra's costs compare to other internal medicine physicians in Oxnard?
Dr. Chopra's average Medicare payment per service is $33. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chopra) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →